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Honorary Presidents: G Rajka (Oslo), K Yamamoto (Tokyo)
Chair: A. Taı¨eb (Bordeaux)
Co-chairs: A. Giannetti (Modena), J. Ring (Munich), K.
Thestrup Pedersen (Aarhus)
Local Organizing Committee: A. Taı¨eb, F. Boralevi, C
Labre`ze (Bordeaux)
Scientific Advisory Board: T Bieber (Bonn), JD Bos (Am-
sterdam), KD Cooper (Cleveland), M Furue (Fukuoka), G
Girolomoni (Verona), J Hanifin (Portland), A Kapp (Hann-
over), TL Diepgen (Heidelberg), DN Leung (Denver), T Luger
(Mu¨nster), JF Nicolas (Lyon), AP Oranje (Rotterdam), Y de
Prost (Paris), T Reunala (Tampere), JF Stalder (Nantes), M
Takigawa (Hamamatsu), K Tamaki (Tokyo), U Wahn (Berlin),
HC Williams (Nottingham), B Wu¨thrich (Zu¨rich)
Scientific Secretariat: F Boralevi, C Labre`ze, Pediatric
Dermatology Unit, Bordeaux Children’s Hospital, France
Website: www.isad2005.org
Wednesday, 14 September 2005: 19.00–21.00: Welcome
cocktail
Thursday 15 September 2005
Session 1: Opening/From History To Genetics 8.00–10.30
Opening Session: Chairs: G Rajka & K Yamamoto
Welcome: A Taı¨eb
Session 1: Chairs: J Ring, K Cooper, J Harper
KL1. 8h15–8.45: D Wallach (France): Atopic Dermatitis And
Dermatological Doctrines: An Historical Approach
KL2. 8.45–9.15 WOCM Cookson (UK): Genetics And Epi-
genetics of Atopic Dermatitis
IC1. 9.15–9.35 TL Diepgen (Germany): Worldwide Variation
Of Risk Factors In Infants With AD
Oral Communications: Genomics-Epidemiology 9.35–10.30
OC1. Microarray Analysis Of Atopic Skin Lesions.
H Sugiura, T Ebise, T Tazawa, K Tanaka, Y Sugiura,
M. Uehara, K. Kikuchi, T. Kimura
OC2. Gene-expression Profiling of Lesional and Atopy
Patched Tested Skin in Patients with Atopic Dermatitis
Using cDNA Microarrays. A Sa¨a¨f, M Bradley, M Tengvall-
Linder, HY Chang, C-F Wahlgren, A Scheynius, M Nor-
denskjo¨ld, PO Brown
OC3. Positional Cloning of a Susceptibility Gene for
Childhood Eczema from Chromosome 1q21. P Edser,
T Street, M Taylor, J Broxholme, JI Harper, WOC Cookson,
MF Moffatt.
OC4. The Links Between Gut Worms, Malaria, and Atop-
ic Dermatitis: A Study in Rural Vietnam. C Flohr
Related Posters:
P1. Epidemiological Characteristics of Atopic Dermati-
tis in India. A J Kanwar
P2. Worldwide Changes in the Prevalence of Eczema
Symptoms. H Williams, A Stewart, E von Mutius, W
Cookson, R Anderson and the ISAAC Study Team.
Session 2: Maturation of the Immune System 11h–13h
Chairs: K Thestrup-Pedersen, T Bieber
KL3. 11.00–11.30 PJ Holt (Australia): Perinatal Maturation
of the Immune System: Implications for the Aetiology
and Pathogenesis of Atopic Dermatitis and Related
Diseases
KL4. 11.30–12.00 E Isolauri (Finland): Gut Microbiota and
Atopic Dermatitis
Oral Communications: Immunology I (12.00–13.00)
OC5. Numerical and Functional Abnormality of Circu-
lating Plasmacytoid DC in Atopic Dermatitis. H Hash-
izume, T Horibe, N Ito, T Ito, M Takigawa.
OC6. The Severity of Atopic Dermatitis Correlates to
Thymic Function. H Just, M Deleuran, C Vestergaard,
B Deleuran, K Thestrup-Pedersen
OC7. Probiotics Provide Clinical Benefit in Moderate
and Severe Atopic Dermatitis: A Randomised Controlled
Trial. S Weston, JA Dunstan, J Roper, L Breckler, A Halbert,
P Richmond, SL Prescott
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OC8. Involvement of Innate Conditioning of Antigen
Presenting Cells by Staphylococcus Aureus Toxin B in
Immune Response of Atopic Dermatitis Patients. M Man-
dron, M-F Aries, F Boralevi F, M Charveron, A Taı¨eb, C Da-
vrinche
Related Posters:
P3. Probiotics in the Management of Atopic Dermatitis.
JH Yim, DH Kim, M-Y Kim, HO Kim, YM Park
P4. The IgE-Bearing B-Cell Receptor Repertoire of
Atopic Dermatitis Patients Shows Unbiased VH-Usage
but Patient-Specific Clonal Expansions Regardless of
Serum Ige Levels. M Mempel, A Gauger, C Schnopp, J
Ring, M Ollert, P Kourilsky, A Lim
Session 3: Infection and Immunity 14.30–16.00
Chairs: JD Bos, JF Nicolas, G Imokawa
KL5. 14.30–15.00 D Leung (USA): The Role of Infection in
Atopic Dermatitis
IC2. 15.00–15.20 T Werfel (Germany): Inflammatory Reac-
tions To S Aureus in AD
Oral Communications: Immunology II 15.20–16.00
OC9. Th2 Cytokines Down-Regulate Cathelicidin Ex-
pression and Increase Skin Susceptibility to Viral Infec-
tion in Atopic Dermatitis (AD) Patients. MD Howell, M
Boguniewicz, JE Streib, C Wong, RL Gallo, DYM Leung
OC10. Microanalysis of Anti-Microbial Peptide, bDefensin-
2, in the Stratum Corneum from Atopic Dermatitis (AD)
Patients. S Asano, M Kawashima, Y Ichikawa, G Imokawa
OC11. The Balance Between Langerhans Cells and
Inflammatory Dendritic Epidermal Cells as a Regulator
of Immunogenic and Tolerogenic Immune Responses in
Atopic Eczema. N Novak, J-PAllam, B Schlu¨tter-Bo¨hmer,
T Bieber, B Kwiek
Related Poster:
P5. Aberrant Blood Dendritic Cells in Atopic Dermatitis.
C Lebre, T van Capel, M Kapsenberg, J Bos, E de Jong
Session 4: Epidermal Inflammation Including Ne-
urogenic Inflammation and Pruritus 16.30–18.30
Chairs: A Giannetti, T Luger, U Gieler
KL6. 16.30–17.00: B Homey (Germany): Chemokines in AD
IC3. 17.00–17.20 : U Gieler (Germany) Is Atopic Dermatitis a
Neurogenic Inflammatory Disease?
IC4. 17.20–17.40: M Takigawa, S Shirahama, T Sakamoto,
H Hashizume (Japan): Anxiety and Atopic Dermatitis
Oral Communications: Epidermal/Neurogenic Inflam-
mation 17.40–18.30
OC12. Intracellular Control Of CTACK/CCL27 (Cutane-
ous T Cell Attracting Chemokine) in Keratinocytes
Through the Nuclear Transcription Factor Kappa B
(NF-kB). C Vestergaard, C Johansen, K Otkjaer, L Iversen,
M Deleuran.
OC13. Brain-Derived Neurotrophic Factor Exerts
Immunomodulatory Functions in Atopic Dermatitis. U
Raap, A Kapp, B Wedi
OC14. Increased Expression and a Potential Anti-In-
flammatory Role of TRAIL in Atopic Dermatitis. E. Vas-
sina, M. Leverkus, L. R. Braathen, H-U. Simon and D. Simon
OC15. Graphology and Atopic Dermatitis. C. Gelmetti,
G Fabrizi, C Colonna, C Guerriero, P Vizziello, V Tarantino,
C. Centofanti and G. Galdo.
Friday 16 September 2005
Session 5: Clinical Research, Prognostic and Severity
Markers 8.00–10.30
Chairs: J Hanifin, T David, C Gelmetti
KL7. 8.00–8.30: T Bieber (Germany): A Novel View on the
Natural History of Atopic Dermatitis
IC5. 8.30–8.50: P Schmid-Grendelmeier et al (Switzerland):
Autoreactivity in Atopic Dermatitis—Induced by Skin Fungi?
Oral Communications: Clinical Research 8.50–10.30
OC16. Expression of Thymic Stromal Lymphopoietin
(TSLP) in Keratinocytes of Atopic Dermatitis Patients
and Normal Controls. CO Park, WW Hao, J H Lee, KH Lee
OC17. Identification of Malassezia Sympodialis in
Patients with Atopic Dermatitis by Polymerase Chain
Reaction and its Impact on Disease Activity. A Roll,
N Juricevic, P Schmid-Grendelmeier
OC18. High Concentrations of Circulating Macrophage
Migration Inhibitory Factor in Patients with ‘Extrinsic’
Atopic Dermatitis. J-S Kim, D-S Yu, J-W Kim
OC19. Elevated Serum Levels of I-309/CCL1 in Patients
with Severe Atopic Dermatitis. N Higashi, Y Niimi, Y Kato,
S Kawana
OC20. Serum Levels of IL-16 and Disease Activity in
Children with Atopic Dermatitis. B Pigozzi, E Tonin,
A Belloni Fortina
OC21. Effect of Caring for a Child with Atopic Dermatitis
and Asthma on Parental Sleep, Depression and Anxiety
Scores: A Prospective Comparative Study. K Moore,
TJ David, CS Murray, HF Child, PD Arkwright
OC22. Flare Cycles, Itch-Scratch Loops and Associated
Downturns in QoL: The Human and Economic Burden of
Atopic Dermatitis on Patients and Caregivers F Turk
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Related Posters:
P6. Comparative Efficacy of Hanifin and Rajka’s Criteria
and U.K. Working Party’s Diagnostic Criteria in Diagno-
sis of Atopic Dermatitis in a Hospital Setting. A.J.
Kanwar
P7. Atopic Dermatitis & The Adolescent Patient. A Taı¨eb
on behalf of the ISOLATE study group
Session 6: Animal Models 11.00–12.30
Chairs: A Kapp, M Furue, H de Verneuil
KL8. 11.00–11.30: T Olivry (USA): Canine AD
IC6. 11.30–11.50: P Verzaal, AP Oranje, L van der Fits, P
Ja¨ger, P Rensen, L Havekes, E Prens, L Nagelkerken (The
Netherlands): Spontaneous Dermatitis in Mice Transgenic
for Human Apolipoprotein C1
Oral Communications: Mouse Models 11.50–12.30
OC23. Establishment of a Mouse Model for Atopic Der-
matitis : Getting New Insights into the Role of T Cells. A
Hennino, J Benetie`re, K Rodet, F Berard, M. Vocanson, A-M
Schmitt, M-F Aries, JF Nicolas
OC24. Collared Mice: A Model to Assess the Effects of
Scratching. S Takeuchi, F Takeuchi, M Furue, SI Katz
OC25. Rapid and Specific Acoustic Analysis of Itch in
AD Model Mouse. H Mizutani, K Umeda, K Tokime, Y
Omoto
Session 7: Skin Barrier 14.00–16.00
Chairs: JF Stalder, G Girolomoni
KL9. 14.00–14.30 A. Hovnanian (France): Netherton Syn-
drome as a Model for Skin Barrier Dysfunction
IC7. 14.30–14.50 JP Hachem (Belgium): Stratum Corneum
pH Regulates Permeability Barrier Homeostasis
IC8. 14.50–15.10 M Brattsand, K Stefansson, T Egelrud.
(Sweden): Kallikreins in the Stratum Corneum
Oral Communications: Skin Barrier 15.10–16.00
OC26. Epicutaneous Sensitization to Aeroallergens in
Infantile Atopic Dermatitis: Determining the Role of Ep-
idermal Barrier Impairment. F Boralevi, T Hubiche, C
Le´aute´-Labre`ze, E Saubusse, S Maurice-Tison, A Taı¨eb.
OC27. Re-Characterization of the Non-Lesional Skin in
Association with Barrier Function and the Severity of
Atopic Dermatitis. H Matsuki, K Kiyokane, T Matsuki, S
Sato, G Imokawa
OC28. Re-Evaluation of the Importance of Barrier Dys-
function in the Non-Lesional Dry Skin of Atopic Derma-
titis: Analysis by Topical Application of a Barrier Cream.
T Matsuki, S Sato, H Matsuki, K Kiyokane, G Imokawa,
Related Posters:
P8. Skin Barrier Damage: Cause or Consequence of
Atopic Dermatitis ? MJ Cork, D Robinson, Y Vasilopoulos,
A Ferguson, M Moustafa, R Tazi-Ahnini, SJ Ward
P9. Epidermal Abnormalities Underlying Defective Bar-
rier in Netherton Syndrome. P Descargues, C Prost,
S Fraitag, J Mazereeuw, G Zambruno, C Bodemer, A
Hovnanian
Session 8: Evidence-Based Therapy, Education and
Quality of Life 16.30–18.30
Chairs: Y de Prost, P Schmid-Grendelmeier, T Diepgen
KL10. 16.30–17.00 H Williams (UK): Updating the NHS HTA
Systematic Review on Evidence-Based Treatments of Atop-
ic Dermatitis
IC9. 17.00–17.20 T Werfel, U Gieler (Germany) and the Ger-
man Atopic Dermatitis Intervention Study (GADIS) Group:




OC29. Parental Education in the Long-Term Manage-
ment in Childhood Atopic Dermatitis. K-B Suhr, Y-S Kim,
J-S Yoon, Y-K Kim, M-S Jang, J-H Lee, J-K Park
OC30. An Audit of the Impact of a Consultation with a
Paediatric Dermatology Team on Quality of Life in In-
fants with Atopic Eczema and Their Families: Further
Validation of the Infants’ Dermatitis Quality of Life Index
and Dermatitis Family Impact Score. PE Beattie, MS
Lewis-Jones
OC31. Comparative Trial of Topical Corticosteroids in
Atopic Dermatitis. T Uenishi, H Sugiura, T Tanaka, M Uehara
Related Posters:
P10. Atopic Dermatitis and Cancer Risk. H Wang, TL
Diepgen
P11. Methotrexate Treatment of Atopic Dermatitis. C
Goujon, N Saad, I Guillot, A Hennino, F Be´rard, JF Nicolas
Gala Evening at the ‘‘Tir au Vol’’, Arcachon, Plage
Pereire
Saturday 17 September
Session 9: European Task Force on Atopic Dermatitis
(ETFAD) Workshop on Allergy Testing in Atopic Derma-
titis D 8.00–10.00
Chairs: U Darsow, F Rance´, T Werfel
OC32. Atopic Eczema And Malassezia. A Scheynius
(Sweden)
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OC33. Studies with Aeroallergen Atopy Patch Tests. U
Darsow, J Ring (Germany)
OC34. Food Atopy Patch Test and Repeated Food
Challenge. S Seidenari, F Giusti (Italy)
OC35. SAFTand APT Using Fresh Foods in Children with
Atopic Dermatitis and Food Allergy. AP Oranje, ACA
Devillers, PG Mulder, FB de Waard-van der Spek. (The
Netherlands)
OC36. Atopy Patch Test with Foods. K Turjanmaa
(Finland)
OC37. The Geneva experience with Epicutaneous Tests
2000–2005 in Atopic Children. J. Lu¨bbe, A. Gkomouzas,
A-M. Calza (Switzerland)
OC38. The Labial Food Challenge in Children with Atop-
ic Eczema. F Rance´ (France)
Discussion of Related Posters (10.00–10.30)
P12. Is the Labial Food Challenge a Useful Tool in the
Management of Food Allergy in Children with Atopic
Dermatitis? F Boralevi, T Hubiche, S Roul, C Le´aute´
Labre`ze, A Taı¨eb.
P13. The Comparison of Atopy Patch Test with Skin
Prick Test in Korean Patients with Atopic Dermatitis.
K-B Suhr, Y-S Kim, J-S Yoon, E-J Oh, E-H Lee, J-H Lee, J-K
Park
P14. Gene Expression Change of PBMC using IGEC
(Immune Gene Expression Chip) by Milk Stimulation
Test in Milk Allergy of Atopic Dermatitis. GW Noh, S Choi
P15. Follow-Up Study of 92 Infants with Multiple Food
Allergies. K Turjanmaa, A-R Ketvell
P16. Alternaria Alternata Patch Tests on a Study Pop-
ulation of 500 Atopic Dermatitis Patients. F Giusti, S
Seidenari
P17. Allergic Sensitization to Common Inhalant Aller-
gens and the Association with Atopic Diseases: Results
of a Population Based in Elderly. M Wolkewitz, D Rot-
henbacher, M Lo¨w, C Stegmaier, H Ziegler, H Wang, H
Brenner, TL Diepgen
Session 10: New Frontiers in Therapy 11.00–12.30
Chairs: D Atherton, A Oranje, M Takigawa
KL 11. 11.00–11.30 M Cork (UK): Treatment of Atopic Der-
matitis from a Skin Barrier Perspective
Oral Communications: Therapy 11.30–12.30
OC39. What Causes Flares of Atopic Eczema? SM
Langan, HC Williams
OC40. Differences in Percutaneous Absorption in Nor-
mal and Atopic Dermatitis Skin in Relation to the Mo-
lecular Weight. I Jakasa, M Verberk, M Esposito, JD Bos,
S Kezic
OC41. N-3/N-6 Polyunsaturated Fatty Acids in a Group
of Patients with Recalcitrant Atopic Dermatitis and the
Influence of Balanced Japanese Traditional Diet. H
Kobayashi, D Tsuruta, M Nanatsue, K Hirai, M Ishii
Related Posters:
P18. Evaluation of the Corticosteroid-Sparing Effect of
an Emollient Milk in a Large Population of Infants Af-
fected by Atopic Dermatitis. M Josse, V Mengeaud, V
Durosier, V Sibaud, R Grimalt, F Cambazard
P19. Refractory Atopic Dermatitis Associated with Cob-
alamine Deficiency Treated with a Single B12 Injection.
M Nabavi
P20. Does Prolonged Topical Application of Tacrolimus
in Children Result in Systemic Accumulation? E Tonin,
B Pigozzi and A Belloni Fortina
Close of Meeting
The page costs of the printing of the program and abstracts have been
sponsored by an educational grant of Novartis Pharma.
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